NCT04553029View on ClinicalTrials.gov

A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS)

CompletedOBSERVATIONAL
Enrollment

3,399

Participants

Timeline

Start Date

September 9, 2020

Primary Completion Date

October 19, 2020

Study Completion Date

October 19, 2020

Conditions
Menopause
Interventions
OTHER

No intervention

This is a cross-sectional survey study evaluating prevalence, severity and associated factors in women with moderate-to-severe menopause-related vasomotor symptoms (MR-VMS).

Trial Locations (3)

Unknown

Site CN86002, Beijing

Site KR82001, Seoul

Site TW88601, Taipei

All Listed Sponsors
lead

Astellas Pharma Singapore Pte. Ltd.

INDUSTRY

NCT04553029 - A Survey Evaluating Prevalence, Severity and Associated Factors in East Asian Women With Moderate-to-severe Menopause-related Vasomotor Symptoms (MR-VMS) | Biotech Hunter | Biotech Hunter